更安全香烟的悖论:理解电子烟对肺的影响
电子烟全球使用持续上升,被宣传为可减少烟草危害的更安全替代品,但其自身致病与致死程度尚未完全明确。本文阐述电子烟工作原理,综述其气溶胶对肺细胞毒性、炎症、抗病原免疫、黏液纤毛清除、氧化应激、DNA损伤、致癌、基质重塑及气道高反应性的影响,并总结对COPD、呼吸道感染、肺癌和哮喘的影响。文章还强调烟液尼古丁或调味化合物如何影响肺毒性,并讨论更安全香烟的悖论及该领域所需研究。
要点
- 电子烟并非无害,其气溶胶可致肺细胞毒性、炎症和氧化应激等。
- 烟液中尼古丁或调味化合物可影响电子烟的肺毒性。
- 电子烟对COPD、呼吸道感染、肺癌和哮喘均有影响。
核心结论
- 电子烟作为减害工具存在悖论:其自身毒性可能削弱其减少传统香烟危害的潜力。
研究设计与样本
- 综述类文章,检索范围未在摘要中报告。
主要发现
- 电子烟气溶胶可影响肺细胞毒性、炎症、抗病原免疫反应、黏液纤毛清除、氧化应激、DNA损伤、致癌、基质重塑和气道高反应性。
- 电子烟对COPD、呼吸道感染、肺癌和哮喘等肺部疾病有影响。
- 烟液中尼古丁或调味化合物的加入可影响肺毒性。
局限性
- 电子烟使用导致发病和死亡的程度尚未完全明确。
- 该领域研究不足,需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Electronic cigarette (e-cigarette) use continues to rise globally. E-cigarettes have been presented as safer alternatives to combustion cigarettes that can mitigate the harm associated with tobacco products; however, the degree to which e-cigarette use itself can lead to morbidity and mortality is not fully defined. Herein we describe how e-cigarettes function; discuss the current knowledge of the effects of e-cigarette aerosol on lung cell cytotoxicity, inflammation, antipathogen immune response, mucociliary clearance, oxidative stress, DNA damage, carcinogenesis, matrix remodelling and airway hyperresponsiveness; and summarise the impact on lung diseases, including COPD, respiratory infection, lung cancer and asthma. We highlight how the inclusion of nicotine or flavouring compounds in e-liquids can impact lung toxicity. Finally, we consider the paradox of the safer cigarette: the toxicities of e-cigarettes that can mitigate their potential to serve as a harm reduction tool in the fight against traditional cigarettes, and we summarise the research needed in this underinvestigated area.
引用
- Allbright K, Villandre J, Crotty Alexander LE, et al. The paradox of the safer cigarette: understanding the pulmonary effects of electronic cigarettes. Eur Respir J. 2024. PMID: 38609098. doi:10.1183/13993003.01494-2023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。